Reuven Yeganeh insider trades: BiomX (PHGE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Reuven reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | PHGE | ↓ Sell | 980,000 | $5.00 | $4.9M | Pyu Pyu Capital LLC | Mar 18, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Reuven Yeganeh's insider trades
Reuven Yeganeh is a director at BiomX (PHGE). Since Mar 17, 2026, Reuven has reported no open-market purchases and 1 sale worth $4.9M on SEC Form 4. In the last 12 months: 1 sale ($4.9M).
Their filings also include grants and awards (2 filings), conversions (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PHGE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.